NHS replaces highest-spend drug with £300m cheaper alternative
This article was taken from: https://www.theguardian.com/society/2018/nov/26/nhs-replaces-highest-spend-drug-with-300m-cheaper-alternative By Alexandra Heal Purchase of ‘biosimilar’ version of adalimumab, used to treat a range of conditions, may free up funds for more nurses The NHS is set to make a record-breaking saving after reaching deals with manufacturers on low-cost “biosimilar” versions of its most expensive drug, according to the health service’s chief executive…